HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroo Terashi Selected Research
Hiroo Terashi Research Topics
Disease
5
Parkinson Disease (Parkinson's Disease)
01/2024 - 08/2019
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2023 - 05/2023
1
Embolism (Embolus)
04/2024
1
Peroneal Neuropathies
10/2023
1
Atrial Fibrillation
09/2023
1
Hematoma
09/2023
1
Dyskinesias (Dyskinesia)
03/2022
1
Pathologic Constriction (Stenosis)
01/2022
1
Brain Diseases (Brain Disorder)
08/2021
1
Infections
08/2021
1
Hyponatremia
01/2021
1
Hypertension (High Blood Pressure)
01/2021
1
Posterior Leukoencephalopathy Syndrome
01/2021
1
Guillain-Barre Syndrome
01/2021
1
Hemiplegia (Spastic Hemiplegia)
12/2020
1
Encephalitis (Encephalitis, Rasmussen)
08/2020
1
Movement Disorders (Movement Disorder)
08/2019
1
Paraneoplastic Cerebellar Degeneration
04/2018
1
Ataxia (Dyssynergia)
04/2018
1
Hashimoto's encephalitis
04/2018
1
Cerebellar Ataxia (Dysmetria)
04/2018
1
Neoplasms (Cancer)
04/2018
Drug/Important Bio-Agent (IBA)
3
istradefylline
IBA
01/2024 - 08/2019
2
Levodopa (L Dopa)
FDA Link
Generic
01/2024 - 03/2022
2
Cytokines
IBA
08/2021 - 08/2020
2
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2021 - 04/2018
1
Messenger RNA (mRNA)
IBA
10/2023
1
Arginine (L-Arginine)
FDA Link
10/2023
1
Glutamine (L-Glutamine)
FDA Link
10/2023
1
Biomarkers (Surrogate Marker)
IBA
10/2023
1
Warfarin (Coumadin)
FDA Link
Generic
09/2023
1
perampanel
IBA
05/2023
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022
1
Interleukin-12 (IL 12)
IBA
08/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2020
1
Chemokines
IBA
08/2020
1
Myelin-Oligodendrocyte Glycoprotein
IBA
08/2020
1
Adenosine A2A Receptor (Adenosine A2A Receptors)
IBA
08/2019
1
Glutens (Glutelin)
IBA
04/2018
1
Steroids
IBA
04/2018
1
Autoantibodies
IBA
04/2018
Therapy/Procedure
7
Therapeutics
10/2023 - 04/2018
1
Thrombectomy
04/2024
1
Activities of Daily Living (ADL)
01/2022
1
Wearable Electronic Devices
04/2020
1
Immunotherapy
04/2018